These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33672177)

  • 1. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.
    Rueca M; Fontana A; Bartolini B; Piselli P; Mazzarelli A; Copetti M; Binda E; Perri F; Gruber CEM; Nicastri E; Marchioni L; Ippolito G; Capobianchi MR; Di Caro A; Pazienza V
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.
    Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH
    Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19.
    Mazzarelli A; Giancola ML; Farina A; Marchioni L; Rueca M; Gruber CEM; Bartolini B; Ascoli Bartoli T; Maffongelli G; Capobianchi MR; Ippolito G; Di Caro A; Nicastri E; Pazienza V;
    PLoS One; 2021; 16(2):e0247041. PubMed ID: 33596245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
    Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
    Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.
    Ma S; Zhang F; Zhou F; Li H; Ge W; Gan R; Nie H; Li B; Wang Y; Wu M; Li D; Wang D; Wang Z; You Y; Huang Z
    Signal Transduct Target Ther; 2021 May; 6(1):191. PubMed ID: 33986253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity.
    Akorli J; Opoku M; Appiah-Twum F; Akpo MS; Ismail RY; Boamah GYK; Obeng-Aboagye E; Adu-Asamoah D; Donkor IO
    BMC Infect Dis; 2024 Sep; 24(1):1020. PubMed ID: 39304808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of oropharyngeal microbiota in healthcare workers post-COVID-19.
    Wei Y; Yu W; Zhang Z; Liu S; Xue J; Wu C; Gao Z; Guo S
    Front Cell Infect Microbiol; 2024; 14():1347345. PubMed ID: 38828262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients.
    Gao M; Wang H; Luo H; Sun Y; Wang L; Ding S; Ren H; Gang J; Rao B; Liu S; Wang X; Gao X; Li M; Zou Y; Liu C; Yuan C; Sun J; Cui G; Ren Z
    Adv Sci (Weinh); 2021 Oct; 8(20):e2102785. PubMed ID: 34423593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity].
    Starikova EV; Galeeva JS; Andreev DN; Sokolov PS; Fedorov DE; Manolov AI; Pavlenko AV; Klimina KM; Veselovsky VA; Zaborovsky AV; Evdokimov VV; Andreev NG; Devkota MK; Fomenko AK; Khar'kovskii VA; Asadulin PO; Kucher SA; Cheremushkina AS; Yanushevich OO; Maev IV; Krikheli NI; Levchenko OV; Ilina EN; Govorun VM
    Ter Arkh; 2022 Oct; 94(8):963-972. PubMed ID: 36286976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
    Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C;
    BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal microbiota dominated by Moraxella spp. is associated with respiratory health in the elderly population: a case control study.
    van den Munckhof EHA; Hafkamp HC; de Kluijver J; Kuijper EJ; de Koning MNC; Quint WGV; Knetsch CW
    Respir Res; 2020 Jul; 21(1):181. PubMed ID: 32664929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose.
    Rhoades NS; Pinski AN; Monsibais AN; Jankeel A; Doratt BM; Cinco IR; Ibraim I; Messaoudi I
    Cell Rep; 2021 Aug; 36(9):109637. PubMed ID: 34433082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19.
    Trøseid M; Holter JC; Holm K; Vestad B; Sazonova T; Granerud BK; Dyrhol-Riise AM; Holten AR; Tonby K; Kildal AB; Heggelund L; Tveita A; Bøe S; Müller KE; Jenum S; Hov JR; Ueland T;
    Crit Care; 2023 Feb; 27(1):69. PubMed ID: 36814280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
    Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
    mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Septic patients in the intensive care unit present different nasal microbiotas.
    Tan XL; Liu HY; Long J; Jiang Z; Luo Y; Zhao X; Cai S; Zhong X; Cen Z; Su J; Zhou H
    Future Microbiol; 2019 Mar; 14(5):383-395. PubMed ID: 30803270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oropharyngeal microbiome profiling and its association with age and heart failure in the elderly population from the northernmost province of China.
    Liu J; He X-Y; Yang K-L; Zhao Y; Dai E-Y; Chen W-J; Raj AK; Li D; Zhuang M; Yin X-H; Ling H
    Microbiol Spectr; 2024 Oct; 12(10):e0021624. PubMed ID: 39162522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.